abiraterone has been researched along with Benign Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Caram, MEV; Henry, E; Jeong, AY; McDevitt, RL; Oerline, MK; Roman, AR; Schwartz, EB; Veenstra, CM | 1 |
| Chehrazi-Raffle, A; Dorff, TB | 1 |
| Caron, P; Guillemette, C; Lacombe, L; Lévesque, É; Pouliot, F; Turcotte, V; Vaillancourt, J; Villeneuve, L | 1 |
| Chanu, P; Kotani, N; Sane, R; Wade, JR; Wang, N; Wilkins, J; Winkler, J; Yoshida, K | 1 |
| Agrawal, M; Almeida, F; Brown, A; Dicker, AP; Fernandez, DC; Garcia, JA; Gratt, J; Iagaru, A; Lutzky, J; Morris, MJ; Petrenciuc, O; Sartor, O; Shore, ND; Smith, MR; Sweeney, C; Vogelzang, NJ; Wong, YN | 1 |
| Abrahamsson, M; Falkenius, J; Henriksson, R; Lindquist, M; Lööv, SÅ; Norin, S; Öhman, D | 1 |
| Belov, AV; Faustova, MR; Mollaev, MD; Nikolskaya, ED; Severin, ES; Sokol, MB; Tereshchenko, OG; Yabbarov, NG; Zabolotsky, AI; Zenin, VA; Zhunina, OA | 1 |
| Doi, T; Endo-Tsukude, C; Fujiwara, Y; Iwasa, S; Matsubara, N; Nakagawa, S; Takahashi, S; Tanaka, A; Tomomatsu, J | 1 |
| Goozner, M | 1 |
| Ratain, MJ | 1 |
3 trial(s) available for abiraterone and Benign Neoplasms
| Article | Year |
|---|---|
Population Pharmacokinetics of Ipatasertib and Its Metabolite in Cancer Patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Androstenes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Models, Biological; Neoplasm Metastasis; Neoplasms; Paclitaxel; Piperazines; Prednisolone; Pyrimidines | 2021 |
Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.
Topics: Aged; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Nitriles; Phenylthiohydantoin; Prognosis; Radium; Survival Rate | 2018 |
Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors.
Topics: Adult; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Japan; Male; Middle Aged; Neoplasms; Prednisolone | 2019 |
8 other study(ies) available for abiraterone and Benign Neoplasms
| Article | Year |
|---|---|
Characterizing Out-of-Pocket Payments and Financial Assistance for Patients Prescribed Abiraterone and Enzalutamide at an Academic Cancer Center Specialty Pharmacy.
Topics: Androstenes; Benzamides; Health Expenditures; Humans; Male; Neoplasms; Nitriles; Pharmacy; Phenylthiohydantoin | 2022 |
Characterizing Out-of-Pocket Payments and Financial Assistance for Patients Prescribed Abiraterone and Enzalutamide at an Academic Cancer Center Specialty Pharmacy.
Topics: Androstenes; Benzamides; Health Expenditures; Humans; Neoplasms; Nitriles; Pharmacy; Phenylthiohydantoin | 2022 |
Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation.
Topics: Androgens; Androstenes; Chromatography, Liquid; Glucuronides; Glucuronosyltransferase; Humans; Liver; Metabolic Networks and Pathways; Microsomes, Liver; Neoplasms; Sapogenins; Steroids; Tandem Mass Spectrometry | 2020 |
[Register for new drugs in cancer care provides a picture of how the drugs are used in the daily clinical practice].
Topics: Androstenes; Antineoplastic Agents; Benzamides; Bevacizumab; Breast Neoplasms; Colorectal Neoplasms; Drug Utilization; Humans; Ipilimumab; Male; Melanoma; Neoplasms; Nitriles; Palliative Care; Phenylthiohydantoin; Pilot Projects; Prostatic Neoplasms; Radium; Registries; Survival Rate; Sweden; Withholding Treatment | 2017 |
Development of novel PLGA nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells.
Topics: A549 Cells; Androstenes; Delayed-Action Preparations; Docetaxel; Drug Carriers; Humans; Nanoparticles; Neoplasms; Polylactic Acid-Polyglycolic Acid Copolymer | 2019 |
Drug approvals 2011: focus on companion diagnostics.
Topics: Androstenes; Androstenols; Antibodies, Monoclonal; Antineoplastic Agents; Axitinib; Biomarkers, Tumor; Brentuximab Vedotin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Crizotinib; Drug Approval; Female; Humans; Imidazoles; Immunoconjugates; Indazoles; Indoles; Ipilimumab; Lung Neoplasms; Male; Melanoma; Molecular Targeted Therapy; Neoplasms; Piperidines; Prostatic Neoplasms; Pyrazoles; Pyridines; Quinazolines; Rare Diseases; Sulfonamides; Survival Analysis; United States; United States Food and Drug Administration; Vemurafenib | 2012 |
Cancer treatment and care: a new and uneasy world.
Topics: Androstenes; Androstenols; Antineoplastic Agents; Humans; Neoplasms; United Kingdom | 2012 |
Importance of food effects for oral oncology drugs.
Topics: Administration, Oral; Androstenes; Androstenols; Antineoplastic Agents; Biological Availability; Eating; Female; Food; Humans; Male; Neoplasms; Orchiectomy; Prostatic Neoplasms | 2012 |